Gastrointestinal Stent Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The gastrointestinal stent market encompasses devices used to palliate or treat obstructions throughout the digestive system, spanning esophageal, gastric, colorectal, biliary, and pancreatic applications. The market was valued at approximately $3.22 billion in 2025 and is expanding steadily due to rising prevalence of gastrointestinal cancers, benign strictures, and an aging global population. Products are primarily categorized into self-expandable metal stents, balloon-expandable stents, and fully covered or partially covered stent-grafts.

• •The market includes stents for esophageal, biliary, duodenal, colonic, and pancreatic indications
• •Growth is driven by increasing cancer incidence and rising adoption of minimally invasive procedures

The rising global incidence of gastrointestinal cancers, including colorectal, pancreatic, and biliary tract cancers, is a primary driver of stent demand. Technological advancements in stent design, such as biodegradable stents, anti-reflux mechanisms, and drug-eluting coatings, are expanding clinical applications and improving patient outcomes. Additionally, the shift toward endoscopic and image-guided minimally invasive procedures reduces hospital stays and complications, making stenting the preferred palliative and therapeutic option.

• •Growing elderly populations and lifestyle-related gastrointestinal disorders are increasing procedure volumes
• •Advances in imaging and endoscopic techniques enable broader and safer stent deployment

The market is segmented by product type into biliary stents, esophageal stents, colonic stents, duodenal stents, and pancreatic stents, as well as by material into metal and polymer-based devices. North America and Europe currently dominate the market due to established healthcare infrastructure, high disease prevalence, and favorable reimbursement policies, while the Asia-Pacific region is experiencing the fastest growth driven by rising healthcare access and large patient populations. Emerging markets in Latin America and the Middle East are also expanding as minimally invasive procedures become more widely available.

• •Biliary stents represent one of the largest segments due to high prevalence of biliary obstructions
• •Asia-Pacific is the fastest-growing regional market due to improving healthcare infrastructure and rising disease burden

What are the recent trends and outlook?

The market is moving toward fully covered metal stents to improve removability and reduce tissue ingrowth, as well as biodegradable stents designed to eliminate long-term foreign body retention. Value-based healthcare models are influencing purchasing decisions, with providers favoring stents that demonstrate improved clinical outcomes and cost-effectiveness. With a projected 5.0% annual growth rate, the market is expected to reach approximately $4.15 billion by 2030, supported by continued innovation, expanding indications, and increasing procedural volumes in both developed and emerging markets.

• •Biodegradable and drug-eluting stents are emerging as high-potential innovations
• •The market is expected to continue steady growth driven by technological advancements and increasing global healthcare access